【编辑推荐】2024年ESC房颤指南将CHA2DS2-VASc评分修订为CHA2DS2-VA评分，取消女性性别作为独立风险因素。本研究通过前瞻性队列分析发现，女性AF卒中患者不仅卒中严重度更高(NIHSS 12 vs 8)，且13.6%的女性患者新评分≤1会落入抗凝治疗灰色地带。研究提示性别中立评分 ...

A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.

房颤患者动态评估CHA?DS?-VASc和HAS-BLED评分对中风和出血风险预测的研究。基于伊朗房颤注册数据的前瞻性研究显示，delta评分和首次随访评分相比基线评分具有更高的AUC（0.69-0.73），提示定期动态评估能有效预测风险变化，优化抗凝治疗。 ### 伊朗心律失常注册 ...

BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...

TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Receive the the latest news, research, and ...

Retrospective data support use of oral anticoagulants for death and MACE risk reduction in patients with end-stage kidney disease and nonvalvular atrial fibrillation who have an elevated CHA2DS2-VASc ...